- |||||||||| umbilical cord mesenchymal stem cells / The Cure Alliance, University of Miami, Jackson Health System
Clinical, P1/2 data, Journal: Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial. (Pubmed Central) - Apr 27, 2021
Treatment was associated with significantly improved patient survival (91% vs 42%, P = .015), SAE-free survival (P = .008), and time to recovery (P = .03). UC-MSC infusions are safe and could be beneficial in treating subjects with COVID-19 ARDS.
- |||||||||| umbilical cord mesenchymal stem cells / Jackson Health System, University of Miami, The Cure Alliance
Trial completion: Use of UC-MSCs for COVID-19 Patients (clinicaltrials.gov) - Nov 12, 2020
P1/2, N=24, Completed,
UC-MSC infusions are safe and could be beneficial in treating subjects with COVID-19 ARDS. Active, not recruiting --> Completed
- |||||||||| umbilical cord mesenchymal stem cells / Jackson Health System, University of Miami, The Cure Alliance
Enrollment closed, Trial completion date, Trial primary completion date: Use of UC-MSCs for COVID-19 Patients (clinicaltrials.gov) - Aug 13, 2020
P1/2, N=24, Active, not recruiting,
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial completion date: May 2022 --> Dec 2020 | Trial primary completion date: Apr 2021 --> Oct 2020
- |||||||||| umbilical cord mesenchymal stem cells / Jackson Health System, University of Miami, The Cure Alliance
Trial completion date, Trial primary completion date: Use of UC-MSCs for COVID-19 Patients (clinicaltrials.gov) - Jun 23, 2020
P1/2, N=24, Recruiting,
Recruiting --> Active, not recruiting | Trial completion date: May 2022 --> Dec 2020 | Trial primary completion date: Apr 2021 --> Oct 2020 Trial completion date: May 2021 --> May 2022 | Trial primary completion date: Dec 2020 --> Apr 2021
- |||||||||| umbilical cord mesenchymal stem cells / Jackson Health System, University of Miami, The Cure Alliance
New P1/2 trial: Use of UC-MSCs for COVID-19 Patients (clinicaltrials.gov) - Apr 20, 2020
P1/2, N=24, Recruiting,
|
